WUPPERTAL, Germany–(BUSINESS WIRE)–Aicuris announced today the appointment of Jacques Dumas, Ph.D., as Chief Scientific Officer (CSO), effective January 1, 2025. Dr. Dumas brings over 30 years of experience in pharmaceutical research and development (R&D), with a strong track record of advancing innovative medicines in oncology and infectious diseases from the discovery to launch. In his new role, Dr. Dumas will oversee Aicuris’ R&D efforts, ensuring alignment with the company’s strat